Sepideh Gholami

Also affiliated with Donald & Barbara Zucker School of Medicine at Hofstra/Northwell

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 20 papers. Top paper: “Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial”.

Trastuzumab Plus Pertuzumab Versus Cetuximab Plus Irinotecan in Patients With RAS/BRAF Wild-Type, HER2-Positive, Metastatic Colorectal Cancer (S1613): A Randomized Phase II Trial

Journal of Clinical Oncology(2025)10.1200/jco-24-01710

N/A

0.458DataRank · unranked

9 citations

Katherine A. Guthrie, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih, Michael J. Overman +15 more

Alliance for clinical trials in Oncology (Alliance) trial A022101/NRG-GI009: a pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

BMC Cancer(2024)10.1186/s12885-024-11899-2

N/A

0.324DataRank · unranked

4 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

Tumor-on-chip modeling of organ-specific cancer and metastasis

Advanced Drug Delivery Reviews(2021)10.1016/j.addr.2021.05.008

N/A

0DataRank · unranked

125 citations

Venktesh S. Shirure, Ye Bi, S. Peter Goedegebuure, Sepideh Gholami, Christopher C.W. Hughes +3 more

Advances in Modeling the Immune Microenvironment of Colorectal Cancer

Frontiers in Immunology(2021)10.3389/fimmu.2020.614300

N/A

0DataRank · unranked

33 citations

Nuala Del Piccolo, Venktesh S. Shirure, Yushuan Peng, Amanda Kirane, Robert J. Canter +4 more

Does adjuvant chemoradiation benefit patients with lymph node-positive biliary tract cancer? A secondary analysis of SWOG S0809.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4104

N/A

0DataRank · unranked

0 citations

Mai T. Duong, David P. Horowitz, Katherine A. Guthrie, Edgar Ben‐Josef, Anthony B. El-Khoueiry +5 more

Adjuvant Chemoradiation in Patients with Lymph Node-Positive Biliary Tract Cancers: Secondary Analysis of a Single-Arm Clinical Trial (SWOG 0809)

Annals of Surgical Oncology(2023)10.1245/s10434-022-12863-9

N/A

0DataRank · unranked

13 citations

Sarah Colby, David P. Horowitz, Katherine A. Guthrie, Edgar Ben‐Josef, Anthony B. El-Khoueiry +6 more

Disparities in treatment and survival in early‐stage hepatocellular carcinoma in California

Journal of Surgical Oncology(2023)10.1002/jso.27423

N/A

0DataRank · unranked

10 citations

Kara T. Kleber, Lauren M. Perry, Mustafa Abidalhassan, Nikia R. McFadden, Sarah B. Bateni +8 more

Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps265

N/A

0DataRank · unranked

8 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zishuo Ian Hu +6 more

A randomized phase 2 study of trastuzumab and pertuzumab (TP) compared to cetuximab and irinotecan (CETIRI) in advanced/metastatic colorectal cancer (mCRC) with HER2 amplification: SWOG S1613.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.140

N/A

0DataRank · unranked

7 citations

Katherine A. Guthrie, Scott Kopetz, Benjamin Tan, Crystal S. Denlinger, Marwan Fakih +15 more

P-228 Randomized phase II trial of encorafenib and cetuximab with or without nivolumab for patients with previously treated, microsatellite stable, BRAFV600E metastatic and/or unresectable colorectal cancer: SWOG S2107

Annals of Oncology(2023)10.1016/j.annonc.2023.04.284

N/A

0DataRank · unranked

2 citations

Katherine A. Guthrie, Scott Kopetz, Rimini Breakstone, Thomas B. Karasic, Zelan Hu +7 more

Randomized, phase II selection study of ramucirumab and paclitaxel versus FOLFIRI in refractory small bowel adenocarcinoma: SWOG S1922.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps784

N/A

0DataRank · unranked

1 citations

Katherine A. Guthrie, Mohamed E. Salem, Katrina S. Pedersen, Aparna Kalyan, Sarah Colby +7 more

Alliance A022101: A pragmatic, randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: Evaluating Radiation, Ablation, and Surgery (ERASur).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps3629

N/A

0DataRank · unranked

1 citations

Paul B. Romesser, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Alliance for Clinical Trials in Oncology (Alliance) trial A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer: evaluating radiation, ablation, and surgery (ERASur)

Research Square(2023)10.21203/rs.3.rs-3773522/v1

N/A

0DataRank · unranked

1 citations

Eric D. Miller, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +13 more

Consideration of Metastasis-Directed Therapy for Patients With Metastatic Colorectal Cancer: Expert Survey and Systematic Review

Clinical Colorectal Cancer(2024)10.1016/j.clcc.2024.01.004

N/A

0DataRank · unranked

2 citations

Brett Klamer, Jordan M. Cloyd, Timothy M. Pawlik, Terence M. Williams, Kathryn Hitchcock +7 more

Exploring the differences in the tumor microenvironment and immuno-oncologic targets in pancreatic ductal adenocarcinomas (PDAC) according to KRAS mutational status

ESMO Gastrointestinal Oncology(2024)10.1016/j.esmogo.2024.100042

N/A

0DataRank · unranked

0 citations

Yasmine Baca, Joanne Xiu, Phillip Walker, Gulam A. Manji, Sepideh Gholami +13 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.tps3633

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

Regulatory T cells in liver metastases: emerging and divergent roles in tumour progression

eGastroenterology(2025)10.1136/egastro-2025-100257

N/A

0DataRank · unranked

9 citations

Ti Yang, Sepideh Gholami, Danielle K. DePeralta, Matthew J. Weiss, Meihong Deng +3 more

Elderly Age Is Associated With More Conservative Treatment of Invasive Melanoma

Anticancer Research(2020)10.21873/anticanres.14266

N/A

0DataRank · unranked

13 citations

Alexandra J. Johns, Alicia A. Gingrich, Sepideh Gholami, Richard J. Bold, Robert J. Canter +2 more

Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur).

Journal of Clinical Oncology(2025)10.1200/jco.2025.43.16_suppl.tps3634

N/A

0DataRank · unranked

0 citations

Kathryn Hitchcock, Qian Shi, Jesse G. Dixon, Sepideh Gholami, Sarah B. White +12 more

The Role of Palliative Surgery for Malignant Bowel Obstruction and Perforation in Advanced Microsatellite Instability-High Colorectal Carcinoma in the Era of Immunotherapy: Case Report

Frontiers in Oncology(2020)10.3389/fonc.2020.00581

N/A

0DataRank · unranked

3 citations

Jingran Ji, James Liu, Manmeet Kaur, Edward Kim, Jun Gong +9 more